Form 4 for WHWK Whitehawk Therapeutics, Inc.

Accepted 2026-07-30 16:04:33 ET · period of report 2026-05-14 · accession 0001602474-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2026-07-30 16:04	2026-05-14	WHWK	Dalal Anupam	Dir	A - Grant	$3.92	+1.28M	4.69M	+37%	+$5.00M
D	2026-07-30 16:04	2026-06-12	WHWK	Dalal Anupam	Dir	A - Grant	$0.00	+38.0K	38.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-05-14	A	A	1,275,510	$3.92	4,685,912	I See footnote	—	—	(F1) Consists of (i) 3,538,288 shares held by Acuta Capital Fund, LP ("Acuta Capital") and (ii) 1,147,624 shares held by Acuta Opportunity Fund, LP. ("Acuta Opportunity Fund"). Acuta Capital Partners, LLC ("Acuta Partners") is the general partner of each of Acuta Capital and Acuta Opportunity Fund. The Reporting Person is the Chief Investment Officer and Managing Member of Acuta Partners. The Reporting Person has voting and investment authority over all of the shares held by each of Acuta Capital and Acuta Opportunity Fund. Each of Acuta Partners and the Reporting Person disclaim beneficial ownership of the shares of common stock held by each of Acuta Capital and Acuta Opportunity Fund except to the extent of their pecuniary interest therein.
2	Derivative	Stock Option (right to buy)	2026-06-12	A	A	38,040	$0.00	38,040	D	$4.16 · — to 2036-06-12	38,040 Common Stock	(F2) Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2026.